You just read:

FDA Grants Approval of IND to Commence a Phase 3 Pivotal Study for ST10 for the Treatment of Iron Deficiency Anaemia in Chronic Kidney Disease

News provided by

Shield Therapeutics

Dec 16, 2013, 02:00 ET